Suppression of ovarian function by a combined oral contraceptive containing 0.02 mg ethinyl estradiol and 2 mg chlormadinone acetate given in a 24/4-day intake regimen over three cycles. [electronic resource]
Producer: 20100920Description: 1195-1201 p. digitalISSN:- 1556-5653
- Adolescent
- Adult
- Algorithms
- Chlormadinone Acetate -- administration & dosage
- Contraceptives, Oral, Combined -- administration & dosage
- Dosage Forms
- Drug Administration Schedule
- Ethinyl Estradiol -- administration & dosage
- Female
- Humans
- Menstrual Cycle -- drug effects
- Ovary -- drug effects
- Ovulation Inhibition -- drug effects
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.